search
Back to results

Safety Study of MotifMESH (cPTFE) in Abdominal Surgery

Primary Purpose

Hernia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
MotifMESH
Sponsored by
Medline Industries
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hernia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Has a non-sterile abdominal wall defect (incisional hernia or fascial defect) and needs to be repaired

Exclusion Criteria:

Non-pregnant, breast feeding or plans to become pregnant during the study; Using adequate birth control methods and agrees to continue using those methods for the duration of the study

Confirmation of incisional hernia or fascial defect by CT scan within 6 months Incisional hernia or facial defect has no necrotic tissue. Such as fascial dehiscence, evisceration, small or large bowel repair, stoma manipulation, small chronic abdominal skin wounds, bowel obstruction

Acceptable state of health and nutrition with pre-albumin levels of ≥ 15 mg/dL (0.15 g/L), serum albumin ≥ 2.0 g/dL (20 g/L). No abnormal pre-surgery laboratory values that, in the opinion of the Principal Investigator, place the subject at risk for the study.

For subjects with Diabetes Mellitus, HbA1C <12%

BMI ≤ 40 kg/m²

Sites / Locations

  • Division of Plastic Surgery

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

MotifMesh

Arm Description

Condensed polytetrafluoroethylene (cPTFE, MotifMESH) mesh

Outcomes

Primary Outcome Measures

Number of Subjects Who Had an Additional Hernia Occur Following Surgery With Condensed Polytetrafluoroethylene (cPTFE, MotifMESH) Mesh
Hernia occurrence at one year after surgery

Secondary Outcome Measures

Full Information

First Posted
May 27, 2011
Last Updated
February 8, 2019
Sponsor
Medline Industries
search

1. Study Identification

Unique Protocol Identification Number
NCT01364233
Brief Title
Safety Study of MotifMESH (cPTFE) in Abdominal Surgery
Official Title
A Prospective Outcome Study of Condensed Fenestrated PTFE Mesh (MotifMESH) in Non-sterile Abdominal Wall Defects
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
May 2011 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medline Industries

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will monitor surgically repaired large abdominal hernias requiring condensed fenestrated polytetrafluoroethylene mesh (cPTFE).
Detailed Description
cPTFEi s a mesh-like product designed to reduce associated post surgical complications.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hernia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
MotifMesh
Arm Type
Other
Arm Description
Condensed polytetrafluoroethylene (cPTFE, MotifMESH) mesh
Intervention Type
Device
Intervention Name(s)
MotifMESH
Intervention Description
Polytetrafluoroethylene (cPTFE) macroporous mesh
Primary Outcome Measure Information:
Title
Number of Subjects Who Had an Additional Hernia Occur Following Surgery With Condensed Polytetrafluoroethylene (cPTFE, MotifMESH) Mesh
Description
Hernia occurrence at one year after surgery
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Has a non-sterile abdominal wall defect (incisional hernia or fascial defect) and needs to be repaired Exclusion Criteria: Non-pregnant, breast feeding or plans to become pregnant during the study; Using adequate birth control methods and agrees to continue using those methods for the duration of the study Confirmation of incisional hernia or fascial defect by CT scan within 6 months Incisional hernia or facial defect has no necrotic tissue. Such as fascial dehiscence, evisceration, small or large bowel repair, stoma manipulation, small chronic abdominal skin wounds, bowel obstruction Acceptable state of health and nutrition with pre-albumin levels of ≥ 15 mg/dL (0.15 g/L), serum albumin ≥ 2.0 g/dL (20 g/L). No abnormal pre-surgery laboratory values that, in the opinion of the Principal Investigator, place the subject at risk for the study. For subjects with Diabetes Mellitus, HbA1C <12% BMI ≤ 40 kg/m²
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gregory A Dumanian, MD
Organizational Affiliation
Northwestern University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Division of Plastic Surgery
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Safety Study of MotifMESH (cPTFE) in Abdominal Surgery

We'll reach out to this number within 24 hrs